Brachytherapy
Volume 6, Issue 2 , Pages 79-80, April 2007

Prostatic acid phosphatase predicts cancer-specific survival after Palladium-103 brachytherapy for prostate cancer

  • L. Christine Fang, M.D.

      Affiliations

    • Radiation Oncology, University of Washington, Seattle, WA
    • ,
  • Michael Dattoli, M.D.

      Affiliations

    • Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, FL
    • ,
  • Kent E. Wallner, M.D.

      Affiliations

    • Radiation Oncology, Puget Sound Health Care System Department of Veteran Affairs, Seattle, WA
    • ,
  • Lawrence True, M.D.

      Affiliations

    • Pathology, University of Washington, Seattle, WA
    • ,
  • Jennifer Cash, A.R.N.P.

      Affiliations

    • Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, FL
    • ,
  • Richard Sorace, M.D., Ph.D.

      Affiliations

    • Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, FL

OR-5 Presentation Time: 9:40 AM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(07)00042-6

doi:10.1016/j.brachy.2007.02.010

Brachytherapy
Volume 6, Issue 2 , Pages 79-80, April 2007

Article Tools